Office of New Drugs Custom Medical Queries (OCMQs) are standardized groupings of similar adverse event terms intended to assist with the identification of potential safety issues during review of adverse event data.
Similar Posts
Dixon Investments Inc. dba ARI – 710087 – 09/17/2025
CGMP/Finished Pharmaceuticals/AdulteratedMedical Gases — Current Good Manufacturing Practice
Pharmaceutical Quality/Manufacturing Standards (CGMP)CDER SBIA On-Demand Learning Library
FDA’s CDER Small Business and Industry Assistance (SBIA) is making available our YouTube learning library – now hundreds of our recordings are readily accessible.FDA Modernizes Clinical Trials with Master Protocols
“FDA Modernizes Clinical Trials with Master Protocols” February 26, 2019 IssueAlembic Pharmaceuticals Limited – 02/06/2021
Alembic Pharmaceuticals Limited – 02/06/2021. Country: India. Record Type: 483Ashfiat Alharamain Energy Support may be harmful due to hidden drug ingredient
The Food and Drug Administration is advising consumers not to purchase or use Ashfiat Alharamain Energy Support, a product promoted and sold for male sexual enhancement on various websites, including Amazon.com (Akkarco, LLC storefront), and possibly in some retail stores.